back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-03 09:15 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
58 - Expiration of rights
|
-1,750,000 vol |
550,000 | |
| Filed 2025-05-06 14:18 Tx date 2025-05-05 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$200,000
+2,000,000 vol $0.10 each |
2,932,000 | |
| Filed 2025-01-23 12:30 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$60,000
+600,000 vol $0.10 each |
932,000 | |
| Filed 2025-01-23 12:23 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$6,000
+60,000 vol $0.10 each |
||
| Filed 2024-10-01 22:28 Tx date 2024-10-01 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,250
+242,000 vol $0.125 each |
332,000 | |
| Filed 2024-09-17 16:48 Tx date 2024-09-13 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,250
+90,000 vol $0.125 each |
90,000 | |
| Filed 2024-09-17 16:47 Tx date 2024-02-21 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-17 12:42 Tx date 2024-07-15 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
+1,750,000 vol |
2,300,000 | |
| Filed 2024-07-17 12:40 Tx date 2024-02-21 |
$KNE
Kane Biotech Inc. |
Huizinga, Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
550,000 | ||
| Filed 2022-03-07 22:04 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
0 | |
| Filed 2022-03-07 17:15 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,651 vol |
69,379 | |
| Filed 2022-03-07 17:14 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
0 | |
| Filed 2022-03-07 17:14 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
51 - Exercise of options
|
$-102,085
-8,500 vol $12.01 each |
||
| Filed 2022-03-07 17:11 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
58 - Expiration of rights
|
-34,000 vol |
8,500 | |
| Filed 2022-03-07 15:09 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+62,448 vol |
62,448 | |
| Filed 2022-03-07 15:07 Tx date 2011-08-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-07 11:02 Tx date 2022-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,283,124
+106,838 vol $12.01 each |
560,395 | |
| Filed 2021-10-27 09:41 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,867,500
-130,000 vol $29.75 each |
65,728 | |
| Filed 2021-10-27 09:40 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$304,000
+95,000 vol $3.20 each |
195,728 | |
| Filed 2021-10-27 09:38 Tx date 2021-10-25 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-399,950
-95,000 vol $4.21 each |
453,557 |